6-Chloro-4-phenylquinazoline-2-carbaldehyde
98%
- Product Code: 157040
CAS:
5958-05-4
Molecular Weight: | 268.7 g./mol | Molecular Formula: | C₁₅H₉ClN₂O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, sealed |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer therapy. Its structure allows for selective modification, making it valuable in creating compounds with anti-tumor activity. Commonly employed in research settings to design molecules targeting epidermal growth factor receptor (EGFR) and other tyrosine kinase pathways. Also utilized in the preparation of fluorescent probes due to its conjugated aromatic system, aiding in cellular imaging and mechanistic studies.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | €322.20 |
+
-
|
250mg | 10-20 days | €591.80 |
+
-
|
6-Chloro-4-phenylquinazoline-2-carbaldehyde
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer therapy. Its structure allows for selective modification, making it valuable in creating compounds with anti-tumor activity. Commonly employed in research settings to design molecules targeting epidermal growth factor receptor (EGFR) and other tyrosine kinase pathways. Also utilized in the preparation of fluorescent probes due to its conjugated aromatic system, aiding in cellular imaging and mechanistic studies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :